Question 1

Does Los Angeles Capital Management own ARWR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Los Angeles Capital Management holds 578 shares of ARWR (Arrowhead Pharmaceuticals in), worth $47,113.

Question 2

How many shares of ARWR does Los Angeles Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management holds 578 shares of ARWR (Arrowhead Pharmaceuticals in).

Question 3

What is Los Angeles Capital Management's ARWR position worth?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management's ARWR position is worth $47,113.

Question 4

Is Los Angeles Capital Management buying or selling ARWR?

Accepted Answer

In Q2 2026, Los Angeles Capital Management reduced its ARWR position by 20,392 shares (-97.2%).

Question 5

When did Los Angeles Capital Management first buy ARWR?

Accepted Answer

Los Angeles Capital Management first reported ARWR in its Q1 2019 13F and has listed it in 24 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	578	-97.2%	$47,113	0.0%	$81.51	0
2026-Q1	Increased	20,970	+12.2%	$1.3M	0.0%	$62.70	28
2025-Q4	Unchanged	18,686	0.0%	$790,605	0.0%	$66.39	0
2025-Q3	Decreased	18,686	-67.8%	$644,480	0.0%	$34.49	0
2025-Q2	New	57,948	—	$915,578	0.0%	$15.80	34